stella
beta
Dapagliflozin Plus Pioglitazone in T1DM — Stella
Recruiting
Back to Type 1 Diabetes Mellitus trials
Phase 4 — Post-approval study. The treatment has been approved, but researchers continue monitoring it in a large population over time.
Trial locations
(3 sites)
United States
University Health System Texas Diabetic Institute, San Antonio, Texas
Israel
Endocrinology and Diabetes Center, Rambam Medical Center, Haifa
Kuwait
Dasman Diabetes Institute, Kuwait City
View full record on ClinicalTrials.gov